Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) pathway signaling

被引:82
作者
Thorburn, Andrew
机构
[1] Univ Colorado Denver, Ctr Comprehens Canc, Aurora, CO 80010 USA
[2] Dept Pharmacol, Aurora, CO USA
[3] Hlth Sci Ctr, Aurora, CO USA
关键词
D O I
10.1097/JTO.0b013e31805fea64
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/ ApolL is a death ligand, a cytokine that activates apoptosis through cell surface death receptors. TRAIL is thought to be important in host tumor surveillance and metastasis suppression, and various therapeutic agonists that activate TRAIL receptors to induce tumor cell apoptosis are in clinical development. This review discusses recent findings about TRAIL pathway signaling and relates the signaling mechanisms to issues that need to be considered as we try to manipulate TRAIL signaling to treat cancer.
引用
收藏
页码:461 / 465
页数:5
相关论文
共 66 条
[21]   Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand cooperates with chemotherapy to inhibit orthotopic lung tumor growth and improve survival [J].
Jin, H ;
Yang, RH ;
Fong, S ;
Totpal, K ;
Lawrence, D ;
Zheng, Z ;
Ross, J ;
Koeppen, H ;
Schwall, R ;
Ashkenazi, A .
CANCER RESEARCH, 2004, 64 (14) :4900-4905
[22]   Targeting death receptors in cancer with Apo2/TRAIL [J].
Kelley, SK ;
Ashkenazi, A .
CURRENT OPINION IN PHARMACOLOGY, 2004, 4 (04) :333-339
[23]   Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas [J].
Koornstra, JJ ;
Kleibeuker, JH ;
van Geelen, CMM ;
Rijcken, FEM ;
Hollema, H ;
de Vries, EGE ;
de Jong, S .
JOURNAL OF PATHOLOGY, 2003, 200 (03) :327-335
[24]   Diarylurea compounds inhibit caspase activation by preventing the formation of the active 700-kilodalton apoptosome complex [J].
Lademann, U ;
Cain, K ;
Gyrd-Hansen, M ;
Brown, D ;
Peters, D ;
Jäättelä, M .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (21) :7829-7837
[25]  
LE H, 2004, J CLIN ONCOL, V22, P2533
[26]   Apo2L/TRAIL and its death and decoy receptors [J].
LeBlanc, HN ;
Ashkenazi, A .
CELL DEATH AND DIFFERENTIATION, 2003, 10 (01) :66-75
[27]   The role of receptor internalization in CD95 signaling [J].
Lee, KH ;
Feig, C ;
Tchikov, V ;
Schickel, R ;
Hallas, C ;
Schütze, S ;
Peter, ME ;
Chan, AC .
EMBO JOURNAL, 2006, 25 (05) :1009-1023
[28]  
Lee SH, 1999, CANCER RES, V59, P5683
[29]   Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma [J].
Lee, SH ;
Shin, MS ;
Kim, HS ;
Lee, HK ;
Park, WS ;
Kim, SY ;
Lee, JH ;
Han, SY ;
Park, JY ;
Oh, RR ;
Kang, CS ;
Kim, KM ;
Jang, JJ ;
Nam, SW ;
Lee, JY ;
Yoo, NJ .
ONCOGENE, 2001, 20 (03) :399-403
[30]   Recruitment of TNF receptor 1 to lipid rafts is essential for TNFα-mediated NF-κB activation [J].
Legler, DF ;
Micheau, O ;
Doucey, MA ;
Tschopp, J ;
Bron, C .
IMMUNITY, 2003, 18 (05) :655-664